Table 1.
Baseline demographic variables of diabetic and nondiabetic patients in the MASS V trial
| Diabetic patients n = 90 |
Nondiabetic patients n = 112 |
P | |
|---|---|---|---|
| Male (%) | 68.9 | 66.1 | 0.78 |
| Age (year)a | 62.5 (55.0, 67.75) | 62.0 (56.0, 68.0) | 0.96 |
| Hypertension (%) | 86.7 | 83.0 | 0.61 |
| Prior MI (%) | 31.1 | 33.0 | 0.89 |
| Angina (%) | 89.9 | 89.3 | 1.0 |
| 3-Vessel CAD (%) | 72.2 | 62.5 | 0.28 |
| LAD disease (%) | 88.9 | 90.2 | 0.95 |
| LM disease (%) | 20.0 | 25.9 | 0.41 |
| SYNTAX scorea | 21.0 (16.0, 26.9) | 19.0 (14.0, 25.0) | 0.27 |
| EFa | 0.67 (0.61, 0.75) | 0.67 (0.61, 0.72) | 0.56 |
| Cholesterola | 165.0 (134.0, 189.0) | 168.0 (147.5, 197.0) | 0.18 |
| LDL-Cholesta | 93.0 (72.0, 117.0) | 98.0 (78.0, 120.8) | 0.17 |
| HDL-Cholesta | 37.0 (30.0, 42.0) | 35.0 (29.3, 46.0) | 0.74 |
| Triglyceridesa | 134.0 (91.0, 196.0) | 128.0 (96.5, 167.5) | 0.95 |
| Glucosea | 146.5 (116.2, 194.5) | 100.0 (94.0, 112.0) | < 0.001 |
| A1ca | 6.9 (6.05, 8.50) | – | – |
| Creatininea | 1.00 (0.88, 1.22) | 0.98 (0.85, 1.20) | 0.65 |
MI myocardial infarction, CAD coronary artery disease, LAD left anterior descending coronary artery, LM left main coronary artery, EF ejection fraction, LDL low-density lipoprotein, HDL high-density lipoprotein, A1c glycated hemoglobin
aPresented as median (25th, 75th percentile)